Satinder Singh

Title: Innovations in Cancer Immunotherapy by Satinder Singh

Introduction

Satinder Singh is an accomplished inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in cancer treatment. His innovative work focuses on enhancing the immunogenicity of killed cancer cells, which has the potential to revolutionize cancer immunotherapy.

Latest Patents

Satinder Singh holds a patent for a pharmaceutical composition of killed cells with substantially retained immunogenicity. This invention discloses a process for lyophilization of treated cells using a solution that contains Trehalose and the amphipathic polymer Polyvinylpyrrolidone. The patent details a method for treating cancer cells, which includes freezing, lyophilizing, and reconstituting the cells. The result is the recovery of immunomodulator-treated dead, yet intact cancerous cells, which can be utilized for effective cancer immunotherapy.

Career Highlights

Satinder Singh is currently associated with Cadila Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing research and development in cancer therapies. Singh's innovative approach and dedication to improving patient outcomes have earned him recognition in the field.

Collaborations

Some of his notable coworkers include Bakulesh Mafatlal Khamar and Nirav Manojkumar Desai. Their collaborative efforts contribute to the ongoing research and development initiatives at Cadila Pharmaceuticals Limited.

Conclusion

Satinder Singh's contributions to cancer immunotherapy through his innovative patent demonstrate the potential for significant advancements in treatment options. His work not only highlights the importance of research in pharmaceuticals but also showcases the impact of collaboration in achieving groundbreaking results.